Publications by authors named "Meagan A Jacoby"

21Publications

Identifying Molecular Markers of Relapse in Myelodysplastic Syndrome.

Oncology (Williston Park) 2018 12;32(12):627-9

View Article

Download full-text PDF

Source
December 2018

Mutation Clearance after Transplantation for Myelodysplastic Syndrome.

N Engl J Med 2018 12;379(24):2380

Washington University School of Medicine, St. Louis, MO

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1813470DOI Listing
December 2018

Mutation Clearance after Transplantation for Myelodysplastic Syndrome.

N Engl J Med 2018 Sep;379(11):1028-1041

From the Department of Pathology and Immunology (E.J.D.), the Department of Medicine, Division of Oncology (M.A.J., C.A.M., N.E., J.S., K.E., J.R., S.E.H., K.B., L.D.W., M.J.C., I.P., J.S.W., G.L.U., D.C.L., J.F.D., P.W., T.J.L., M.J.W.), the McDonnell Genome Institute (G.S.C., C.A.M., H.A., R.S.F., C.C.F., M.O.), the Department of Medicine, Division of Hospital Medicine (R.S.), and Siteman Biostatistics Shared Resource, Siteman Cancer Center (K.T.), Washington University School of Medicine in St. Louis, St. Louis; and Massachusetts General Hospital Cancer Center, Boston (T.A.G.).

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMoa1804714
Publisher Site
http://dx.doi.org/10.1056/NEJMoa1804714DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309244PMC
September 2018

TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

N Engl J Med 2016 11;375(21):2023-2036

the Department of Internal Medicine, Division of Oncology (J.S.W., L.D.W., G.L.U., A.G., M.H.T., I.P., R.R., T.A.F., K.E.S.-G., R.V., S.T.O., C.N.A., A.F.C., M.A.S., M.A.J., S.E.H., K.L., M.R.J., M.J.W., P.W., D.C.L., J.F.D., T.J.L.), and the Division of Biostatistics (J.D.B.), and the Department of Pathology and Immunology (E.J.D., B.T., Y.-S.L.), Washington University School of Medicine, and McDonnell Genome Institute, Washington University in St. Louis (A.A.P., C.A.M., C.C.F., M.O., R.S.F., R.K.W., L.D.W., T.J.L.) - both in St. Louis; the Departments of Internal Medicine (A.H., N.K., M.J.S., W.S.) and Pharmacy (R.W.K.), University of Chicago, Chicago; and the Department of Internal Medicine (T.A.G.), Massachusetts General Hospital, Boston.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1605949DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217532PMC
November 2016

Implications of Tumor Clonal Heterogeneity in the Era of Next-Generation Sequencing.

Trends Cancer 2015 Dec 25;1(4):231-241. Epub 2015 Nov 25.

Department of Medicine, Division of Oncology, Washington University School of Medicine, St Louis, MO, USA; Alvin J. Siteman Cancer Center, Washington University School of Medicine, St Louis, MO, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trecan.2015.10.006DOI Listing
December 2015

Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia.

Am J Hematol 2014 May 3;89(5):487-92. Epub 2014 Mar 3.

Department of Medicine, Division of Oncology, Section of Bone Marrow Transplantation and Leukemia, Washington University School of Medicine, St. Louis, Missouri.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.23663DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378713PMC
May 2014

Acquired copy number alterations of miRNA genes in acute myeloid leukemia are uncommon.

Blood 2013 Oct 5;122(15):e44-51. Epub 2013 Sep 5.

Jane Anne Nohl Division of Hematology, Department of Medicine, University of Southern California, Los Angeles, CA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2013-03-488007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3795465PMC
October 2013

Detection of copy number alterations in acute myeloid leukemia and myelodysplastic syndromes.

Expert Rev Mol Diagn 2012 Apr;12(3):253-64

Department of Internal Medicine, Washington University School of Medicine, Division of Oncology, Stem Cell Biology Section, Campus Box 8007, 660 South Euclid Avenue, St Louis, MO 63110, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/erm.12.18DOI Listing
April 2012

Systematic mutagenesis of the murine gammaherpesvirus 68 M2 protein identifies domains important for chronic infection.

J Virol 2008 Apr 30;82(7):3295-310. Epub 2008 Jan 30.

Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia 30329, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.02234-07DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268483PMC
April 2008

The murine gammaherpesvirus 68 M2 gene is required for efficient reactivation from latently infected B cells.

J Virol 2005 Feb;79(4):2261-73

Center for Emerging Infectious Diseases, Yerkes National Primate Research Center, School of Medicine, Emory University, Atlanta, GA 30329, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.79.4.2261-2273.2005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC546582PMC
February 2005

Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation.

J Virol 2002 Feb;76(4):1790-801

Division of Microbiology and Immunology, Yerkes Regional Primate Research Center, Emory University, Atlanta, Georgia 30329, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC135904PMC
http://dx.doi.org/10.1128/jvi.76.4.1790-1801.2002DOI Listing
February 2002